Drug Side Effects
Search
TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY
TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY
was reported 25 times
TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
CD22-directed Immunoconjugate [EPC]
2
0.0007
1
Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]
1
0.0003
2
Bile Acid [EPC]
7
0.0003
3
Selective T Cell Costimulation Blocker [EPC]
1
0.0002
4
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
3
0.0001
5
B Lymphocyte Stimulator-specific Inhibitor [EPC]
2
0.0001
6
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
7
0.0001
7
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
7
0.0001
8
Azole Antifungal [EPC]
8
0.0001
9
Alkylating Drug [EPC]
12
0.0000
10
Topoisomerase Inhibitor [EPC]
3
0.0000
11
Calcineurin Inhibitor Immunosuppressant [EPC]
5
0.0000
12
Complement Inhibitor [EPC]
2
0.0000
13
CD20-directed Cytolytic Antibody [EPC]
7
0.0000
14
Purine Antimetabolite [EPC]
2
0.0000
15
Nucleoside Metabolic Inhibitor [EPC]
5
0.0000
16
BCL-2 Inhibitor [EPC]
1
0.0000
17
Janus Kinase Inhibitor [EPC]
2
0.0000
18
Kinase Inhibitor [EPC]
6
0.0000
19
Folate Analog Metabolic Inhibitor [EPC]
4
0.0000
20
Corticosteroid [EPC]
10
0.0000
21
Opioid Agonist [EPC]
1
0.0000
22
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000